11 March 2021
Cartherics is pleased to announce that on 8 March 2021 a review paper was approved for production and accepted for publication in the journal Frontiers in Genetics, section Cancer Genetics.
Titled: A role for integrin-linked kinase in colorectal cancer growth and progression via regulating senescence and immunity, the paper is a collaboration between Cartherics, […]
Melbourne, Australia, 04 March 2021.
Cartherics Pty Ltd announced today the grant of a European patent entitled “Genetically modified cells and uses thereof”. The patent covers aspects of Cartherics’ chimeric antigen receptor (CAR) technology, particularly in relation to its CAR directed against the tumour-associated antigen, TAG-72.
This patent is […]
By Leigh Dayton
4 March 2021
In 1966 Alan Trounson was enjoying a hike in the hills above Edinburgh, Scotland with his colleague Ian Wilmut when Wilmut revealed a secret. His team at the Roslin Institute had cloned a […]
Monash Grad Rachelle Duffin joins the team
1 March 2021
By Leigh Dayton
Fresh from a Research Assistant job at the Peter MacCallum Cancer Centre and a Bachelor of Science (Honours) from Monash University, Rachelle Duffin took up her new role at Cartherics at the beginning of February.
She’s “delighted and honoured” to be supervised by Cartherics […]
It all happened at Cape Schanck ……
By Leigh Dayton
24 February 2021
2020 was a rough year everywhere for everyone, including Cartherics’ hard-working team. By way of a thank you CEO Alan Trounson, Chairman Bob Moses and Chief Operating Officer Ian Nisbet hosted a company come-one come-all event this month at the Royal Automobile Club […]
A survey reveals nearly US$100 market capitalisation
23 February 2021
A survey conducted by Washington DC based BioInformant assesses the growth of the CAR-T arm of immunotherapy research and development. The summary is posted below.
At first the trend was subtle, but the tide has swelled as CAR-T therapies like Kymriah, Yescarta, Tecartus, and […]
By Leigh Dayton
4 February 2021
Not only is Alan Trounson Cartherics CEO and a leader in embryonic stem cell science, he’s also a pioneer in IVF technology. Back in 1980 the then embryologist made headlines for his participation in the birth of Australia’s first IVF baby, Candice Reed.
Thanks to this […]
By Leigh Dayton
21 December 2020
As a rough year for all comes to an end, Cartherics is delighted to raise a toast to Anisha Balachandran and Van Thi To. Anisha dressed-up for a pared-down graduation ceremony, and Van passed her Confirmation of Candidature Review with flying colours.
Cartherics CEO Alan Trounson is the […]
Writing today Research Australia’s INSPIRE magazine, Cartherics CEO Alan Trounson highlights the role GSK plays in supporting medical research
December 17 2020
By Leigh Dayton
For forty years the science-led global healthcare company has sponsored its GSK Award for Research Excellence. The Award acknowledges outstanding Australian researchers and provides an $80,000 (tax free) independent research grant to the […]
Back People Not Projects
By Ian Nisbet*
“If plan A doesn’t work, the alphabet has 25 more letters – 46 if you’re in Japan.” (Claire Cook, Seven Year Switch)
In the late 1980s and early 1990s I was working at CSL during the years leading up to its public listing and prior to it becoming the behemoth it […]
Cartherics’ mission is the development of novel, “off-the-shelf” (allogeneic) immune cell therapy products for the treatment of cancer.
Stay informed about our latest news and developments
© Copyright 2022 | Cartherics Pty ltd
